Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang DingTai Pharmaceutical Technology is a leading Chinese Contract Research Organization (CRO) that provides comprehensive preclinical and clinical research services to the global biopharmaceutical industry. The company specializes in preclinical safety evaluation (toxicology), pharmacokinetics (PK), pharmacodynamics (PD), and bioanalytical services, operating facilities that comply with international GLP standards. DingTai Pharm supports the entire drug development lifecycle, from early-stage lead optimization to clinical trial management and regulatory submission. By leveraging its integrated service platform, the company aims to accelerate the R&D process for innovative small molecules, biologics, and cell and gene therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang DingTai Pharmaceutical Technology.